Esomfril 40 Injection
Marketer
Arenon Healthcare Private Limited
Salt Composition
Esomeprazole (40mg)
Overview Esomfril 40 Injection
Injected Esomfril 40 is a medication that diminishes gastric acid secretion. It treats acid-related gastrointestinal disorders, including acid reflux and other hyperacidity conditions. It's also employed to prevent stress ulcers in critically ill patients and prophylactically before anesthesia to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), this intravenous medication, administered by a healthcare provider, is reserved for patients where injection is deemed clinically preferable to oral formulations. Dosage and treatment length are individualized based on your condition and response. Optimizing treatment involves consuming smaller, more frequent meals and abstaining from caffeinated beverages, spicy foods, and high-fat diets. Common, generally mild, side effects include injection site reactions, nausea, headache, dizziness, flatulence, diarrhea, abdominal pain, and fundic gland polyps. Persistent or bothersome symptoms warrant medical attention. Discuss bone loss (osteoporosis) prevention strategies, such as calcium and vitamin D supplementation, with your physician. Esomfril 40 Injection is contraindicated in individuals with severe hepatic impairment, those using HIV medications, those with a history of PPI allergy, or existing osteoporosis. Pregnant or lactating women should seek medical advice. Alcohol consumption should be avoided due to its potential to exacerbate gastric acid production and worsen symptoms.
Primary Ingredients of Esomfril 40 Injection
No text provided to rephrase.
Uses of Esomfril 40 Injection
Managing Gastroesophageal Reflux Disease (GERD)
Major Benefits of Esomfril 40 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Esomfril 40 Injection:
- Injection site reaction
- Headache
- Dizziness
- Dryness in mouth
- Nausea
- Abdominal pain
- Constipation
- Flatulence
- Diarrhea
- Fundic gland polyps
How to use Esomfril 40 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Esomfril 40 Injection works:
Esomprazole 40 mg injection, a proton pump inhibitor, lowers stomach acid production, providing relief from acid indigestion and heartburn.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Esomfril 40 Injection concurrently with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
The use of Esomfril 40 Injection during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Limited data in humans indicates potential risk associated with Esomfril 40 Injection use during lactation. The medication might transfer to breast milk, posing a possible threat to the infant. Therefore, its use while breastfeeding is likely inadvisable.
DrivingCONSULT YOUR DOCTOR
The effect of Esomfril 40 Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
For patients with significantly impaired kidney function, Esomfril 40 Injection requires careful administration and potential dose modification. Individuals with mild to moderate kidney impairment do not necessitate dose alteration. Physician consultation is advised.
LiverCAUTION
For patients with severe hepatic impairment, Esomfril 40 Injection requires careful administration and potential dosage modification. Individuals with mild to moderate liver disease do not necessitate dosage alteration. Physician consultation is advised.
What if you forget to take Esomfril 40 Injection :
Should you forget a dose of Esomfril 40 Injection, seek medical advice.
Facts to Know About Esomfril 40 Injection
| Label | Value |
|---|---|
| Type of Compound | Benzimidazole sulfinyl compound |
| Potential for Dependence | None. |
| Medication Classification | Stomach and bowel system |
| Mechanism of Action | Gastric acid secretion suppressants |



